February 17, 2017

Trade Groups Petition FDA To Reconsider ‘Intended Use’ Regulation Amendment

Three major medical product trade groups petitioned the FDA Feb. 8 to stay and reconsider the amendments the agency made to its intended use regulations in January.

The groups – Medical Information Working Group, Pharmaceutical Research and Ma...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight